Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Lopresti

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLaura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Nuclear Medicine and Biology|May 31, 2020
Development of a PET radioligand selective for cerebral amyloid angiopathyEric E Abrahamson, Jeffrey S Stehouwer, Alberto L Vazquez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2015
Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PETYin J Chen, Bedda L Rosario, Wenzhu Mowrey, et al.
Synapse (New York, N.Y.)|July 23, 2011
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyRajesh Narendran, Diana Martinez, Neale Scott Mason, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinomaNeale S Mason, Brian J Lopresti, James Ruszkiewicz, et al.
Seminars in Nuclear Medicine|December 22, 2015
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of DementiaLaura B Eisenmenger, Eugene J Huo, John M Hoffman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 10, 2005
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-BJulie C Price, William E Klunk, Brian J Lopresti, et al.
Synapse (New York, N.Y.)|March 21, 2009
Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studiesRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Frontiers in Psychiatry|September 25, 2023
Low thalamic activity during a digit-symbol substitution task is associated with symptoms of subjective cognitive declineAkiko Mizuno, Helmet Talib Karim, Maria J Ly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2026
BiomarkersLaura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLaura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Nuclear Medicine and Biology|May 31, 2020
Development of a PET radioligand selective for cerebral amyloid angiopathyEric E Abrahamson, Jeffrey S Stehouwer, Alberto L Vazquez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2015
Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PETYin J Chen, Bedda L Rosario, Wenzhu Mowrey, et al.
Synapse (New York, N.Y.)|July 23, 2011
Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography studyRajesh Narendran, Diana Martinez, Neale Scott Mason, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinomaNeale S Mason, Brian J Lopresti, James Ruszkiewicz, et al.
Seminars in Nuclear Medicine|December 22, 2015
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of DementiaLaura B Eisenmenger, Eugene J Huo, John M Hoffman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 10, 2005
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-BJulie C Price, William E Klunk, Brian J Lopresti, et al.
Synapse (New York, N.Y.)|March 21, 2009
Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studiesRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Frontiers in Psychiatry|September 25, 2023
Low thalamic activity during a digit-symbol substitution task is associated with symptoms of subjective cognitive declineAkiko Mizuno, Helmet Talib Karim, Maria J Ly, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2026
BiomarkersLaura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Pageof 11